Works matching IS 10648542 AND DT 2019 AND VI 28 AND IP 5
Results: 10
Relying on Data and Behavior Science to Unlock Real Change.
- Published in:
- Applied Clinical Trials, 2019, v. 28, n. 5, p. 22
- By:
- Publication type:
- Article
Work Planning & Approaches to Overcome Bottlenecks.
- Published in:
- Applied Clinical Trials, 2019, v. 28, n. 5, p. 16
- By:
- Publication type:
- Article
A Roadmap for Implementing RBM and Quality Management.
- Published in:
- Applied Clinical Trials, 2019, v. 28, n. 5, p. 10
- By:
- Publication type:
- Article
ONCOLOGY PHARMA DE-RISK THROUGH COLLABORATIONS, NOVEL COMBINATION TARGETS.
- Published in:
- 2019
- By:
- Publication type:
- Interview
SHARPLESS OUTLINES PRIORITIES AT FDA.
- Published in:
- Applied Clinical Trials, 2019, v. 28, n. 5, p. 6
- By:
- Publication type:
- Article
A RESOURCE FOR GLOBAL RESEARCH REQUIREMENTS.
- Published in:
- Applied Clinical Trials, 2019, v. 28, n. 5, p. 6
- By:
- Publication type:
- Article
LONG-TERM IMPLANT TO TREAT OPIOID DEPENDENCE.
- Published in:
- Applied Clinical Trials, 2019, v. 28, n. 5, p. 5
- Publication type:
- Article
WEAPONIZING CANCER AS A EUROPEAN ELECTION PLEDGE.
- Published in:
- Applied Clinical Trials, 2019, v. 28, n. 5, p. 5
- By:
- Publication type:
- Article
MORE EFFICIENT, INFORMATIVE CLINICAL TRIALS IS THE GOAL OF FDA LEADERS.
- Published in:
- Applied Clinical Trials, 2019, v. 28, n. 5, p. 4
- By:
- Publication type:
- Article
For AD, Non-Pharma Efforts Becoming More Critical.
- Published in:
- Applied Clinical Trials, 2019, v. 28, n. 5, p. 2
- By:
- Publication type:
- Article